Diabetes Supplies Insurance Claim Denied? How to Appeal
Insurance denied your diabetes supplies — test strips, lancets, CGM sensors, or pump supplies? Learn how to appeal and get the coverage you're entitled to.
Why Diabetes Supplies Claims Get Denied
Diabetes supplies — blood glucose test strips, lancets, continuous glucose monitors (CGMs), insulin pump supplies, and related equipment — are medically necessary devices for managing diabetes and preventing life-threatening complications. The American Diabetes Association (ADA) Standards of Medical Care in Diabetes establishes evidence-based criteria for these supplies, yet insurers routinely deny them.
CGM denied as "not medically necessary." Continuous glucose monitors (e.g., Dexcom G7, Abbott FreeStyle Libre, Medtronic Guardian) are denied when the insurer's criteria are not met. Medicare and most commercial insurers now recognize CGMs as medically necessary for insulin-treated diabetes. Common coverage criteria require a diagnosis of Type 1 (ICD-10 E10.x) or Type 2 (ICD-10 E11.x) diabetes managed with insulin, a treating physician's prescription, and in some cases documentation of hypoglycemia unawareness or frequent low blood glucose episodes. The ADA's 2024 Standards of Medical Care recommends CGM for all persons using insulin, recognizing its proven benefits for reducing A1C and time in hypoglycemia.
Insulin pump supplies denied. Insulin pumps and their supplies (infusion sets, reservoirs, cartridges) are denied when the insurer requires documentation of specific criteria not present in the submitted records. Common criteria include: Type 1 or insulin-requiring Type 2 diabetes (ICD-10 E10.x/E11.x), inadequate glycemic control on multiple daily injections, ability and willingness to manage the pump, and a physician knowledgeable in pump therapy. The ADA Standards of Medical Care supports continuous subcutaneous insulin infusion (CSII) as an effective treatment option for people who are not achieving glycemic goals with multiple daily injections.
Quantity limitations. Insurers impose quantity limits on test strips, CGM sensors, and pump supplies. When your physician orders quantities exceeding plan limits — for example, more frequent testing due to insulin dose adjustments or hypoglycemia unawareness — the excess may be denied.
Brand not on formulary / preferred brand required. Plans may cover only specific CGM brands or test strip brands on their formulary. Claims for non-preferred brands are denied, often without explanation of how to obtain a formulary exception.
Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained or expired. CGMs, insulin pumps, and related supplies typically require prior authorization. Renewals must be reauthorized periodically. Expired authorizations are a common denial trigger.
Documentation insufficient. Clinical records do not adequately demonstrate that the patient meets the coverage criteria. This is often a documentation problem — the clinical need exists, but the physician's records don't explicitly state the criteria the insurer requires.
Your Legal Rights
ACA Essential Health Benefits. Medical equipment and supplies necessary for managing chronic disease, including diabetes, fall within the Essential Health Benefits framework for non-grandfathered individual and small group plans. Diabetes supplies should be covered as durable medical equipment or as part of the preventive services benefit.
State diabetes supply mandates. Many states have enacted laws requiring health insurers to cover diabetes supplies without excessive cost-sharing. States with specific diabetes equipment coverage mandates include California, New York, Texas, Illinois, Minnesota, Virginia, and others. Check your state's insurance department website for applicable mandates.
ERISA — For employer-sponsored plans, ERISA §1133 guarantees a written denial explanation and a full and fair review. You have at least 180 days to file an internal appeal.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
Medicare CGM coverage. Effective January 2022, Medicare Part B covers therapeutic CGMs for insulin-treated diabetes without requiring fingerstick testing as a condition of coverage. If you are on Medicare and your CGM was denied, this coverage expansion is a strong appeal argument.
External Independent Review: Complete Guide" class="auto-link">External review rights. Independent external review is available for medical necessity denials under non-grandfathered plans. External reviewers who are endocrinologists frequently overturn diabetes supply denials.
Step-by-Step Appeal Strategy
Step 1: Identify the Denial Reason
Read your denial letter carefully. Is the denial for "not medically necessary," a quantity limit, a formulary issue, a prior authorization problem, or a documentation deficiency? The response strategy differs for each.
Step 2: Gather Your Documentation Checklist
- Denial letter with specific reason and policy provision cited
- Physician's letter of medical necessity that explicitly addresses the insurer's coverage criteria, including:
- ICD-10 diabetes diagnosis code (E10.x for Type 1, E11.x for Type 2)
- Insulin treatment regimen (multiple daily injections or pump)
- Current A1C and glycemic control history
- History of hypoglycemia events or hypoglycemia unawareness (if applicable)
- Why the specific device/supply is necessary for this patient's management
- Recent A1C lab results
- Blood glucose log showing frequency and pattern of testing
- Hypoglycemia incident documentation (if applicable)
- ADA Standards of Medical Care in Diabetes (Section 7: Diabetes Technology) — cite the relevant recommendation
- Insurer's coverage criteria document for CGM or insulin pump supplies
- Prior authorization records (if expired)
- State diabetes supply mandate (if applicable)
Step 3: Address ADA Standards in the Appeal
The ADA's Standards of Medical Care in Diabetes (updated annually) is the authoritative clinical guideline for diabetes management. In your appeal, cite the relevant ADA recommendation:
- For CGM: "The ADA Standards of Medical Care in Diabetes (Section 7) recommends CGM for all persons using insulin to improve glycemic management and reduce hypoglycemia. This is a Level A recommendation — the highest level of evidence."
- For insulin pump (CSII): "The ADA recommends CSII for people with Type 1 diabetes who have not achieved their glycemic goals with multiple daily injections."
Your physician's letter should reference these standards by name and section.
Step 4: Write the Appeal
Your appeal letter should address each denial criterion with specific clinical evidence. Reference state diabetes supply mandates if applicable. Request approval of the specific devices and quantities ordered by your physician.
Step 5: Escalate If Needed
Request external review by an endocrinologist if the internal appeal fails. File a complaint with your state Department of Insurance citing applicable diabetes supply mandates. For Medicare denials, escalate through the Medicare appeals process.
Documentation Checklist
- Denial letter with specific reason and policy provision cited
- Physician letter of medical necessity (addresses each coverage criterion)
- ICD-10 diagnosis codes (E10.x or E11.x with appropriate complication codes)
- Recent A1C lab results
- Blood glucose log or CGM download showing testing pattern
- Insulin treatment records
- Hypoglycemia documentation (if applicable)
- ADA Standards of Medical Care (Section 7 on Diabetes Technology)
- Insurer's coverage criteria document
- State diabetes supply mandate (if applicable)
- Prior authorization records (if expired/missing)
Fight Back With ClaimBack
Denied diabetes supplies leave patients without the tools they need to manage a serious chronic disease, increasing the risk of dangerous complications. These denials are frequently reversed when the ADA Standards of Medical Care are cited and the physician documentation directly addresses the insurer's criteria. ClaimBack generates a professional appeal letter in 3 minutes, citing the ADA Standards, applicable state diabetes supply mandates, and your legal rights under ERISA and the ACA.
Start your free claim analysis →
Free analysis · No credit card required · Takes 3 minutes
Related Reading
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides